Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Elaine Lam and Rebecca Shay.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.764 |
|
|
|
-
Shay R, Nicklawsky A, Gao D, Lam ET. A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma. Clin Genitourin Cancer. 2021 08; 19(4):370-370.e7.
Score: 0.764